MedTrace Logo

Blood Flow Restriction and Creatine Supplementation in Women

NCT05877417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-06-12

No results posted yet for this study

Summary

This research is examining the changes in muscle size, muscle function, body composition, strength, and blood vessel health. Specifically, the changes in these variables over the course of 8 weeks of training with or without blood flow restriction (BFR) and the supplementation of creatine or placebo (dextrose, a sugar in the form of a powder which is the standard placebo). Creatine monohydrate (Cr) is the most popular supplement for athletes and benefits all populations, however women are still very hesitant to take it due to the misconception of weight gain. This study will look to measure those muscle and body changes with exercise.

Conditions

  • Physical Inactivity

Interventions

DIETARY_SUPPLEMENT

Creatine Monohydrate

Creatine supplementation for 8 weeks, 5g daily. A 5 day loading phase will be implemented with 20g daily for 5 days.

DEVICE

Blood Flow Restriction

Blood Flow Restriction Cuffs applied during exercise

OTHER

Exercise

Participants will exercise

Sponsors & Collaborators

  • University of Central Florida

    lead OTHER

Principal Investigators

  • Paola M Rivera · University of Central Florida

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-17
Primary Completion
2023-12-20
Completion
2024-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05877417 on ClinicalTrials.gov